https://www.novumpr.nl/2018/12/03/kite-announces-two-year-data-for-yescarta-axicabtagene-ciloleucel-in-patients-with-refractory-large-b-cell-lymphoma/?utm_source=rss&utm_medium=rss&utm_campaign=kite-announces-two-year-data-for-yescarta-axicabtagene-ciloleucel-in-patients-with-refractory-large-b-cell-lymphoma NovumPR press releases Mon, 03 Dec 2018 08:44:57 +0000 hourly 1 https://wordpress.org/?v=6.8.2